As our RNAseq analysis of the catulin reporter GFP + breast cancer cells revealed enrichment in genes important for tumor-vasculature interactions, we stained isolated tumor samples with antibody against PECAM (CD31)—well known endothelial marker. This evidence concerns the gene PECAM1 and breast carcinoma.